Alyson Haslam

Title(s)	Research Data Analyst, Epidemiology & Biostatistics
School	School of Medicine
Phone	--
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas. J Cancer Policy. 2024 Apr 06; 100476. Zugman M, Haslam A, Prasad V. PMID: 38588795.

View in: PubMed Mentions:
Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis. Eur J Cancer. 2024 Mar 16; 202:114019. Lam M, Olivier T, Haslam A, Tuia J, Prasad V. PMID: 38522156.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review. Target Oncol. 2024 Mar 11. Crotty P, Kari K, Hughes GK, Ladd C, McIntire R, Gardner B, Peña AM, Ferrell S, Tuia J, Cohn J, Haslam A, Prasad V, Vassar M. PMID: 38466535.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation. Monash Bioeth Rev. 2024 Mar 09. Prasad V, Haslam A. PMID: 38459404.

View in: PubMed Mentions: Fields:
Eth Ethics
Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials. Cancer Med. 2024 Mar; 13(5):e7049. Benjamin DJ, Haslam A, Prasad V. PMID: 38491813; PMCID: PMC10943275.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Justification for unequal allocation ratios in clinical trials: A scoping review. Contemp Clin Trials. 2024 Feb 29; 139:107484. Nay J, Haslam A, Prasad V. PMID: 38431132.

View in: PubMed Mentions: Fields:
Med Medicine (General)The Therapeutics
Translation:Humans
Estimation of eligibility for and response to CAR-T therapy in the United States. Blood Adv. 2024 Feb 27; 8(4):1032-1036. Haslam A, Hoeg TB, Prasad V. PMID: 38039516; PMCID: PMC10920105.

View in: PubMed Mentions: 1 Fields:
Hem Hematology
Financial conflicts of interest among presenters, panellists and moderators at haematology and oncology FDA workshops. Eur J Clin Invest. 2024 Feb 26; e14184. Miller SL, Haslam A, Prasad V. PMID: 38407501.

View in: PubMed Mentions: Fields:
Med Medicine (General)
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiol Infect. 2024 Feb 16; 152:e51. Høeg TB, Haslam A, Prasad V. PMID: 38361448.

View in: PubMed Mentions: Fields:
Com Communicable Diseases Epi Epidemiology
Translation:Humans PHPublic Health
Discrepancies in Estimating Excess Death by Political Party Affiliation During the COVID-19 Pandemic. JAMA Intern Med. 2024 Jan 01; 184(1):118-119. Dasaro C, Haslam A, Prasad V. PMID: 38010692.

View in: PubMed Mentions: Fields:
Int Internal Medicine
Translation:Humans PHPublic Health
Assessing patient burden and benefit: A decade of cabozantinib clinical trials. Int J Cancer. 2024 Apr 15; 154(8):1464-1473. Hughes GK, Sajjadi NB, Gardner B, Ramoin JK, Tuia J, Haslam A, Prasad V, Vassar M. PMID: 38108216.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy. J Cancer Policy. 2023 Dec 05; 39:100462. Ranganathan S, Haslam A, Tuia J, Prasad V. PMID: 38061492.

View in: PubMed Mentions: Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
Cancer Drug Price and Novelty in Mechanism of Action. JAMA Netw Open. 2023 Dec 01; 6(12):e2347006. Miljkovic MD, Tuia J, Olivier T, Haslam A, Prasad V. PMID: 38079171; PMCID: PMC10714245.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Systematic Review and Meta-Analysis of Randomized Trials Testing Interventions to Reduce Physician Burnout. Am J Med. 2024 Mar; 137(3):249-257.e1. Haslam A, Tuia J, Miller SL, Prasad V. PMID: 37890569.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Eligibility for Human Leukocyte Antigen-Based Therapeutics by Race and Ethnicity. JAMA Netw Open. 2023 10 02; 6(10):e2338612. Olivier T, Haslam A, Tuia J, Prasad V. PMID: 37883087; PMCID: PMC10603498.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
An Analysis of Studies Pertaining to Masks in Morbidity and Mortality Weekly Report: Characteristics and Quality of Studies through 2023. Am J Med. 2024 Feb; 137(2):154-162.e1. Høeg TB, Haslam A, Prasad V. PMID: 37777144.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Flu advice in the U.S. news media changed during the COVID-19 pandemic but not the evidence. Eur J Epidemiol. 2023 Oct; 38(10):1115-1117. Brown E, Haslam A, Prasad V. PMID: 37697025.

View in: PubMed Mentions: Fields:
Epi Epidemiology
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer. BMC Med. 2023 09 08; 21(1):344. Olivier T, Haslam A, Prasad V. PMID: 37679732; PMCID: PMC10485976.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs. JAMA Oncol. 2023 09 01; 9(9):1238-1244. Lam M, Olivier T, Haslam A, Tuia J, Prasad V. PMID: 37471095; PMCID: PMC10360002.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Evidence Base for Health Care Strategies to Protect Vulnerable Patients During the COVID-19 Pandemic. JAMA Oncol. 2023 08 01; 9(8):1150. Haslam A, Prasad V. PMID: 37261802.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans Cells PHPublic Health
Multiple myeloma: challenges with deciding the optimal sequencing strategy. Front Pharmacol. 2023; 14:1231720. Walia A, Haslam A, Tuia J, Prasad V. PMID: 37465528; PMCID: PMC10350499.

View in: PubMed Mentions:
Cross-sectional analysis characterizing the use of rank preserving structural failure time in oncology studies: changes to hazard ratio and frequency of inappropriate use. Trials. 2023 Jun 03; 24(1):373. Prasad V, Kim MS, Haslam A. PMID: 37270500; PMCID: PMC10239129.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)The Therapeutics
Translation:Humans
Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022. J Cancer Policy. 2023 09; 37:100426. Olivier T, Smith CEP, Haslam A, Addeo A, Prasad V. PMID: 37270063.

View in: PubMed Mentions: Fields:
Neo Neoplasms Pub Public Health
Scoping Review of Published Oncology Meta-analyses in High-Impact Oncology Journals. JAMA Netw Open. 2023 06 01; 6(6):e2318877. Haslam A, Tuia J, Prasad V. PMID: 37358855; PMCID: PMC10293908.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020. BMC Cancer. 2023 May 17; 23(1):448. Olivier T, Haslam A, Prasad V. PMID: 37198564; PMCID: PMC10189952.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
Profile of the Oncology Physician Workforce and the Characteristics of Attrition. JCO Oncol Pract. 2023 07; 19(7):465-472. Tuia J, Haslam A, Prasad V. PMID: 37186885.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Cross-sectional analysis of open payments for physicians at designated hemophilia centers in the US (2018-2020). Thromb Res. 2023 07; 227:40-44. Haslam A, Prasad V. PMID: 37210957.

View in: PubMed Mentions: Fields:
Vas Vascular Diseases
Translation:Humans
Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin Lymphoma: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023 05 01; 183(5):435-441. Banerjee T, Kim MS, Haslam A, Prasad V. PMID: 36939665; PMCID: PMC10028543.

View in: PubMed Mentions: 1 Fields:
Int Internal Medicine
Translation:Humans
Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials? J Cancer Policy. 2023 06; 36:100423. Olivier T, Haslam A, Prasad V. PMID: 37075841.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
The definition of long COVID used in interventional studies. Eur J Clin Invest. 2023 Aug; 53(8):e13989. Haslam A, Olivier T, Prasad V. PMID: 36964995.

View in: PubMed Mentions: 6 Fields:
Med Medicine (General)
Translation:Humans
Omission of Critical Information From Clinical Trial Reports-What to Do About Uninterpretable Results. JAMA Oncol. 2023 04 01; 9(4):459-460. Olivier T, Haslam A, Prasad V. PMID: 36821106.

View in: PubMed Mentions: Fields:
Neo Neoplasms
The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review. J Cancer Res Clin Oncol. 2023 Aug; 149(10):7355-7362. Bhatt A, Haslam A, Prasad V. PMID: 36928160; PMCID: PMC10374733.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
The response rate by tumour type for tissue-agnostic approved drugs. Eur J Cancer. 2023 05; 184:117-119. Haslam A, Prasad V. PMID: 36913833.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Design, power, and alpha levels in randomized phase II oncology trials. ESMO Open. 2023 02; 8(1):100779. Haslam A, Olivier T, Prasad V. PMID: 36736072; PMCID: PMC10024120.

View in: PubMed Mentions: Translation:Humans
Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology Journals. JAMA Netw Open. 2023 02 01; 6(2):e2254405. Buck E, Haslam A, Tuia J, Prasad V. PMID: 36723940; PMCID: PMC9892954.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
Comparability of Control and Comparison Groups in Studies Assessing Long COVID. Am J Med. 2023 Jan 25. Haslam A, Prasad V. PMID: 36708796; PMCID: PMC9912142.

View in: PubMed Mentions: 2 Fields:
Med Medicine (General)
Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers. BMC Cancer. 2023 Jan 13; 23(1):46. Haslam A, Olivier T, Tuia J, Prasad V. PMID: 36639625.

View in: PubMed Mentions: 3 Fields:
Neo Neoplasms
Sotorasib in KRASG12C mutated lung cancer: Can we rule out cracking KRAS led to worse overall survival? Transl Oncol. 2022 Dec 26; 28:101591. Olivier T, Haslam A, Prasad V. PMID: 36577165.

View in: PubMed Mentions: 1
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis. Br J Haematol. 2023 03; 200(5):587-594. Etekal T, Koehn K, Sborov DW, McClune B, Prasad V, Haslam A, Berger K, Booth C, Al Hadidi S, Abdallah AO, Goodman A, Mohyuddin GR. PMID: 36495317.

View in: PubMed Mentions: 1 Fields:
Hem Hematology
Translation:Humans
Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020. JAMA Intern Med. 2022 Dec 01; 182(12):1319-1320. Miljkovic MD, Tuia JE, Olivier T, Haslam A, Prasad V. PMID: 36315136; PMCID: PMC9623474.

View in: PubMed Mentions: 2 Fields:
Int Internal Medicine
Translation:Humans
Financial conflicts of interest of OncoAlert: An informal oncology professional network. J Cancer Policy. 2022 Dec; 34:100369. Powell K, Kakkilaya A, Haslam A, Prasad V. PMID: 36396090.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
A systematic review of basket and umbrella trials in oncology: the importance of tissue of origin and molecular target. Eur J Cancer. 2023 01; 178:227-233. Haslam A, Olivier T, Tuia J, Prasad V. PMID: 36493558.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
Brentuximab Vedotin in Advanced Hodgkin's Lymphoma. N Engl J Med. 2022 10 20; 387(16):1527. Haslam A, Prasad V. PMID: 36260800.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020). BMJ Open. 2022 10 07; 12(10):e064458. Jenei K, Haslam A, Olivier T, Miljkovíc M, Prasad V. PMID: 36207035; PMCID: PMC9558788.

View in: PubMed Mentions: 2 Fields:
Med Medicine (General)
Translation:Humans CTClinical Trials
Estimation of time cost of anti-cancer drugs approved based on comparisons to best supportive care: A cross sectional analysis. J Cancer Policy. 2022 Dec; 34:100363. Prasad V, Olivier T, Chen EY, Haslam A. PMID: 36162749.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
FDA validation of surrogate endpoints in oncology: 2005-2022. J Cancer Policy. 2022 Dec; 34:100364. Walia A, Haslam A, Prasad V. PMID: 36155118.

View in: PubMed Mentions: 3 Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
Characteristics of Facebook's third-party medical fact checkers. Digit Health. 2022 Jan-Dec; 8:20552076221120318. Haslam A, Prasad V. PMID: 36003316; PMCID: PMC9393657.

View in: PubMed Mentions:
Dose modification rules and availability of growth factor support: A cross-sectional study of head-to-head cancer trials used for US FDA approval from 2009 to 2021. Eur J Cancer. 2022 09; 172:349-356. Olivier T, Haslam A, Prasad V. PMID: 35830842.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Eventual success rate and predictors of success for oncology drugs tested in phase I trials. Int J Cancer. 2023 01 15; 152(2):276-282. Haslam A, Olivier T, Powell K, Tuia J, Prasad V. PMID: 35716142.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms
Translation:Humans CTClinical Trials
Impact of a Farm-to-School Nutrition and Gardening Intervention for Native American Families from the FRESH Study: A Randomized Wait-List Controlled Trial. Nutrients. 2022 Jun 23; 14(13). Taniguchi T, Haslam A, Sun W, Sisk M, Hayman J, Jernigan VBB. PMID: 35807781; PMCID: PMC9268191.

View in: PubMed Mentions: 4 Fields:
Nut Nutritional Sciences
Translation:Humans
Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials. JAMA Netw Open. 2022 05 02; 5(5):e2212327. Ahmed N, Vengalasetti Y, Haslam A, Prasad V. PMID: 35576006; PMCID: PMC9112068.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
Duration of treatment in oncology clinical trials: does the duration change when the same drug moves from the experimental arm to the control arm? ESMO Open. 2022 06; 7(3):100480. Haslam A, Olivier T, Thawani R, Prasad V. PMID: 35468562; PMCID: PMC9271471.

View in: PubMed Mentions: 1 Translation:Humans
Frequency of survival to hospital discharge after cardiopulmonary resuscitation on FOX TV's The Resident. Eur J Emerg Med. 2022 04 01; 29(2):142-143. Herrera-Perez D, Gill J, Haslam A, Crain T, Klossner Q, Prasad V. PMID: 35210379.

View in: PubMed Mentions: Fields:
Eme Emergency Medicine
Translation:Humans
Targeted therapy in lung cancer: Are we closing the gap in years of life lost? Cancer Med. 2022 09; 11(18):3417-3424. Benjamin DJ, Haslam A, Gill J, Prasad V. PMID: 35315222; PMCID: PMC9487872.

View in: PubMed Mentions: 5 Fields:
Neo Neoplasms
Translation:Humans
Characteristics of oncology podcasts: Attitudes, speakers, conflicts. J Cancer Policy. 2022 06; 32:100329. Akman EG, Powell K, Haslam A, Prasad V. PMID: 35560266.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
Quality of biomarker defined subgroups in FDA approvals of PD-1/PD-L1 inhibitors 2014 to 2020. Int J Cancer. 2022 06 01; 150(11):1905-1910. Kim MS, Xu A, Haslam A, Prasad V. PMID: 35182072.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms
Translation:Humans
Design and Methods of a Participatory Healthy Eating Intervention for Indigenous Children: The FRESH Study. Front Public Health. 2022; 10:790008. Blue Bird Jernigan V, Taniguchi T, Haslam A, Williams MB, Maudrie TL, Nikolaus CJ, Wetherill MS, Jacob T, Love CV, Sisson S. PMID: 35296044; PMCID: PMC8920553.

View in: PubMed Mentions: 4 Fields:
Pub Public Health
Translation:Humans Animals
Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours. Eur J Cancer. 2022 03; 164:95-104. Maniar A, Haslam A, Prasad V. PMID: 35182927.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
The effect of food prescription programs on chronic disease management in primarily low-income populations: A systematic review and meta-analysis. Nutr Health. 2022 Sep; 28(3):389-400. Haslam A, Gill J, Taniguchi T, Love C, Jernigan VB. PMID: 35108144; PMCID: PMC10150796.

View in: PubMed Mentions: 6 Fields:
Nut Nutritional Sciences
Translation:Humans Animals
Development and Implementation of a Hybrid Online and In-Person Food Sovereignty and Nutrition Education Curriculum for Native American Parents: The FRESH Study. Health Educ Behav. 2023 06; 50(3):430-440. Haslam A, Love C, Taniguchi T, Williams MB, Wetherill MS, Sisson S, Weedn AE, Jacob T, Blue Bird Jernigan V. PMID: 34991400; PMCID: PMC9981305.

View in: PubMed Mentions: 3 Fields:
Beh Behavioral Sciences Edu Education Pub Public Health
Translation:Humans Animals
Reporting of Physicians' or Investigators' Choice of Treatment in Oncology Randomized Clinical Trials. JAMA Netw Open. 2022 01 04; 5(1):e2144770. Olivier T, Haslam A, Prasad V. PMID: 35061042; PMCID: PMC8783268.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
How Often do Medical Specialties Question the Practices that They Perform? An Empirical, Cross-Sectional Analysis of the Published Literature. Inquiry. 2022 Jan-Dec; 59:469580211061034. Haslam A, Powell K, Prasad V. PMID: 35322719; PMCID: PMC8961376.

View in: PubMed Mentions: 1 Fields:
Hea Health Services
Translation:Humans
Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature. JAMA Intern Med. 2022 01 01; 182(1):76-78. Kim MS, Cai J, Maniar A, Kartika T, Haslam A, Prasad V. PMID: 34491275; PMCID: PMC8424524.

View in: PubMed Mentions: 3 Fields:
Int Internal Medicine
Translation:Humans
A preliminary study of the rate of hospitals and satellite clinics worldwide for top US cancer centers. J Cancer Policy. 2022 03; 31:100319. Prasad V, Haslam A, Tuia J. PMID: 35559871.

View in: PubMed Mentions: Fields:
Neo Neoplasms Pub Public Health
Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action. JAMA Netw Open. 2021 12 01; 4(12):e2138793. Olivier T, Haslam A, Prasad V. PMID: 34905002; PMCID: PMC8672232.

View in: PubMed Mentions: 19 Fields:
Med Medicine (General)
Translation:Humans
Artificial intelligence and magnetic resonance imaging may not make cancer screening better. J Cancer Policy. 2022 03; 31:100314. Powell K, Kim MS, Haslam A, Prasad V. PMID: 35559866.

View in: PubMed Mentions: Fields:
Neo Neoplasms Pub Public Health
Translation:Humans
The frequency of assessment of progression in randomized oncology clinical trials. Cancer Rep (Hoboken). 2022 07; 5(7):e1527. Haslam A, Gill J, Prasad V. PMID: 34821077; PMCID: PMC9327664.

View in: PubMed Mentions: 3 Fields:
Neo Neoplasms
Translation:Humans
Overall survival for oncology drugs approved for genomic indications. Eur J Cancer. 2022 01; 160:175-179. Haslam A, Kim MS, Prasad V. PMID: 34819251.

View in: PubMed Mentions: 3 Fields:
Neo Neoplasms
Translation:Humans
Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020. JAMA Netw Open. 2021 11 01; 4(11):e2135123. Haslam A, Lythgoe MP, Greenstreet Akman E, Prasad V. PMID: 34792592; PMCID: PMC8603079.

View in: PubMed Mentions: 9 Fields:
Med Medicine (General)
Translation:Humans
An Empirical Analysis of Precision Previvorship: Are Familial and High-Risk Cancer Preventive Programs Evidence Based? Am J Med. 2022 02; 135(2):179-183. Powell K, Haslam A, Prasad V. PMID: 34678212.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals. Dig Dis Sci. 2022 06; 67(6):2011-2018. Yopes MC, Mozeika AM, Liebling S, Haslam A, Prasad V, Lebwohl B. PMID: 34463882.

View in: PubMed Mentions: Fields:
Gas Gastroenterology
Translation:Humans
The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009-2018. BMC Cancer. 2021 Aug 03; 21(1):889. Haslam A, Gill J, Crain T, Herrera-Perez D, Chen EY, Hilal T, Kim MS, Prasad V. PMID: 34344325; PMCID: PMC8336285.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms
Translation:Humans
Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials. J Clin Epidemiol. 2021 11; 139:80-86. Olivier T, Haslam A, Prasad V. PMID: 34311054.

View in: PubMed Mentions: 2 Fields:
Epi Epidemiology
Translation:Humans
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020. Ann Oncol. 2021 07; 32(7):926-932. Haslam A, Kim MS, Prasad V. PMID: 33862157.

View in: PubMed Mentions: 22 Fields:
Neo Neoplasms
Translation:Humans
Perceived Environments and Physical Activity Among American Indian Adults Living in Oklahoma: The THRIVE Study. Prog Community Health Partnersh. 2021; 15(3):267-268. Haslam A, Taniguchi T, Love C, Jacob T, Cannady TK, Standridge J, Grammar M, Fox J, Spiegel J, Crain T, Jernigan VBB. PMID: 37934415.

View in: PubMed Mentions: Fields:
Pub Public Health
Perceived Environments and Physical Activity Among American Indian Adults Living in Oklahoma: The THRIVE Study. Prog Community Health Partnersh. 2021; 15(3):285-296. Haslam A, Taniguchi T, Love C, Jacob T, Cannady TK, Standridge J, Grammar M, Fox J, Spiegel J, Crain T, Jernigan VBB. PMID: 37934418.

View in: PubMed Mentions: Fields:
Pub Public Health
The response rate of alternative treatments for drugs approved on the basis of response rate. Int J Cancer. 2021 02 01; 148(3):713-722. Haslam A, Gill J, Prasad V. PMID: 32700797.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms
Translation:Humans
FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019. JAMA Intern Med. 2020 06 01; 180(6):912-914. Chen EY, Haslam A, Prasad V. PMID: 32338703; PMCID: PMC7186918.

View in: PubMed Mentions: 20 Fields:
Int Internal Medicine
Translation:Humans
Estimation of US patients with cancer who may respond to cytotoxic chemotherapy. Future Sci OA. 2020 May 25; 6(8):FSO600. Maldonado EB, Parsons S, Chen EY, Haslam A, Prasad V. PMID: 32983564; PMCID: PMC7491026.

View in: PubMed Mentions: 8
Comparison of Industry Payments in 2017 With Annual Salary in a Cohort of Academic Oncologists. JAMA Intern Med. 2020 05 01; 180(5):797-799. Gill J, Haslam A, Crain T, Herrera-Perez D, Prasad V. PMID: 32202604; PMCID: PMC7091392.

View in: PubMed Mentions: 4 Fields:
Int Internal Medicine
Translation:Humans
Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials. J Natl Compr Canc Netw. 2020 04; 18(4):428-433. Hazim A, Mills G, Prasad V, Haslam A, Chen EY. PMID: 32259790.

View in: PubMed Mentions: 7 Fields:
Neo Neoplasms
Translation:Humans
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs. JAMA Netw Open. 2020 03 02; 3(3):e200423. Haslam A, Gill J, Prasad V. PMID: 32150268; PMCID: PMC7063495.

View in: PubMed Mentions: 85 Fields:
Med Medicine (General)
Translation:Humans
Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials. JAMA Netw Open. 2020 03 02; 3(3):e200363. Haslam A, Herrera-Perez D, Gill J, Prasad V. PMID: 32129865; PMCID: PMC7057133.

View in: PubMed Mentions: 21 Fields:
Med Medicine (General)
Translation:Humans
Medical Reversals in Family Practice: A Review. Curr Ther Res Clin Exp. 2020; 92:100579. Haslam A, Livingston C, Prasad V. PMID: 32180846; PMCID: PMC7063107.

View in: PubMed Mentions: 1 Fields:
Pha Pharmacology
Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's Actions. Mayo Clin Proc. 2020 02; 95(2):424-426. Haslam A, Gill J, Prasad V. PMID: 32029095.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
An Empirical Analysis of Noninferiority Studies in Oncology: Are They Good Enough? J Natl Compr Canc Netw. 2020 02; 18(2):161-167. Haslam A, Gill J, Prasad V. PMID: 32023529.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
Medical reversals in low- and middle-income countries. Int J Health Plann Manage. 2020 Mar; 35(2):631-638. Haslam A, Prasad V, Livingston C. PMID: 31710144.

View in: PubMed Mentions: 1 Fields:
Hea Health Services Hea Health Services Research
Translation:Humans
Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib. JAMA Netw Open. 2019 11 01; 2(11):e1916091. de Almeida Carvalho LM, de Oliveira Sapori Avelar S, Haslam A, Gill J, Prasad V. PMID: 31755953; PMCID: PMC6902826.

View in: PubMed Mentions: 7 Fields:
Med Medicine (General)
Translation:Humans
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals. Elife. 2019 06 11; 8. Herrera-Perez D, Haslam A, Crain T, Gill J, Livingston C, Kaestner V, Hayes M, Morgan D, Cifu AS, Prasad V. PMID: 31182188; PMCID: PMC6559784.

View in: PubMed Mentions: 28 Fields:
Bio Biology
Translation:Humans
Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice? Mayo Clin Proc. 2019 06; 94(6):951-956. Chapa J, Haslam A, Prasad V. PMID: 31171133.

View in: PubMed Mentions: 2 Fields:
Med Medicine (General)
Translation:Humans PHPublic Health
Confirmatory Trials for Drugs Approved on a Single Trial. Circ Cardiovasc Qual Outcomes. 2019 06; 12(6):e005494. Haslam A, Prasad V. PMID: 31137954.

View in: PubMed Mentions: 5 Fields:
Car Cardiology Vas Vascular Diseases
Translation:Humans
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw Open. 2019 05 03; 2(5):e192535. Haslam A, Prasad V. PMID: 31050774; PMCID: PMC6503493.

View in: PubMed Mentions: 500 Fields:
Med Medicine (General)
Translation:Humans
Where Does the Blame for High Health Care Costs Go? An Empirical Analysis of Newspaper and Journal Articles Criticizing Health Care Costs. Am J Med. 2019 06; 132(6):718-721. Haslam A, Crain T, Gill J, Herrera-Perez D, Prasad V. PMID: 30639552.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology. Eur J Cancer. 2019 01; 106:196-211. Haslam A, Hey SP, Gill J, Prasad V. PMID: 30528804.

View in: PubMed Mentions: 59 Fields:
Neo Neoplasms
Translation:Humans
Multivitamins Do Not Reduce Cardiovascular Disease and Mortality and Should Not Be Taken for This Purpose: How Do We Know That? Circ Cardiovasc Qual Outcomes. 2018 07; 11(7):e004886. Haslam A, Prasad V. PMID: 29991647.

View in: PubMed Mentions: 2 Fields:
Car Cardiology Vas Vascular Diseases
Translation:Humans
Association between dietary pattern scores and the prevalence of colorectal adenoma considering population subgroups. Nutr Diet. 2018 04; 75(2):167-175. Haslam A, Wagner Robb S, Hébert JR, Huang H, Ebell MH. PMID: 29280253.

View in: PubMed Mentions: 6 Fields:
Nut Nutritional Sciences
Translation:Humans Animals